Akebia Therapeutics, Inc. (AKBA) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Akebia Therapeutics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-77.40
Cash-Rich Deficit
P/B Ratio
12.70
Weak
WeakModerateStrong
Earnings Yield
-1.29%
Yield Gap
Profitability Health
2025Return on Equity
-16.39%
Weak
WeakModerateStrong
Operating Margin
9.95%
Weak
WeakModerateStrong
Net Profit Margin
-2.26%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
47.46%
Strong
WeakModerateStrong
Net Income Growth
92.30%
Strong
WeakModerateStrong
EPS Growth
93.70%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.13
Moderate
WeakModerateStrong
Quick Ratio
1.04
Moderate
WeakModerateStrong
Asset Turnover
0.63x
Moderate
WeakModerateStrong
Inventory Turnover
2.53x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
16.42%
Strong
WeakModerateStrong
EV / Free Cash Flow
6.55x
Strong
WeakModerateStrong
Net Debt / EBITDA
1.45x
Moderate
WeakModerateStrong
Interest Burden (EBT / EBIT)
-0.158
Weak
WeakModerateStrong
Return on Invested Capital
9.26%
Weak
WeakModerateStrong
Cash Conversion Cycle
21.11 days
Moderate
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for AKBA.
View Financial Statements